Hamid Erfanian - Apr 13, 2022 Form 4 Insider Report for ENZO BIOCHEM INC (ENZ)

Role: Chief Executive Officer
Signature: /s/ Hamid Erfanian
Stock symbol: ENZ
Transactions as of: Apr 13, 2022
Transactions value $: $29,000
Form type: 4
Date filed: 4/14/2022, 01:52 PM
Previous filing: Nov 10, 2021
Next filing: Jun 17, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ENZ	Common Stock, $0.01 Par Value	Award	$29K	+10K	+3.85%	$2.90	270K	Apr 13, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ENZ	Stock Option (to acquire Common Stock)	Award	$0	+700K		$0.00	700K	Nov 8, 2021	Common Stock	700K	$3.39	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.